These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18279531)

  • 1. Bench-to-bedside review: Clostridium difficile colitis.
    Gould CV; McDonald LC
    Crit Care; 2008; 12(1):203. PubMed ID: 18279531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile: the increasingly difficult pathogen.
    Pop-Vicas A; Neill MA
    Crit Care; 2008; 12(1):114. PubMed ID: 18304376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile associated infection, diarrhea and colitis.
    Hookman P; Barkin JS
    World J Gastroenterol; 2009 Apr; 15(13):1554-80. PubMed ID: 19340897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile infection: a worldwide disease.
    Burke KE; Lamont JT
    Gut Liver; 2014 Jan; 8(1):1-6. PubMed ID: 24516694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.
    Al-Tawfiq JA; Rabaan AA; Bazzi AM; Raza S; Noureen M
    Am J Infect Control; 2020 Oct; 48(10):1152-1157. PubMed ID: 32122671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America.
    Balassiano IT; Yates EA; Domingues RMCP; Ferreira EO
    J Med Microbiol; 2012 Feb; 61(Pt 2):169-179. PubMed ID: 22116982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of Clostridium difficile-associated disease in North America and Europe.
    Kuijper EJ; Coignard B; Tüll P; ; ;
    Clin Microbiol Infect; 2006 Oct; 12 Suppl 6():2-18. PubMed ID: 16965399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.
    Vedantam G; Clark A; Chu M; McQuade R; Mallozzi M; Viswanathan VK
    Gut Microbes; 2012; 3(2):121-34. PubMed ID: 22555464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection.
    Heinlen L; Ballard JD
    Am J Med Sci; 2010 Sep; 340(3):247-52. PubMed ID: 20697257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underestimation of Clostridium difficile infection among clinicians: an international survey.
    Mavros MN; Alexiou VG; Vardakas KZ; Tsokali K; Sardi TA; Falagas ME
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2439-44. PubMed ID: 22450740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.
    Barbut F; Gariazzo B; Bonné L; Lalande V; Burghoffer B; Luiuz R; Petit JC
    Infect Control Hosp Epidemiol; 2007 Feb; 28(2):131-9. PubMed ID: 17265393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New trends in Clostridium difficile virulence and pathogenesis.
    Denève C; Janoir C; Poilane I; Fantinato C; Collignon A
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypervirulent strains of Clostridium difficile.
    Cookson B
    Postgrad Med J; 2007 May; 83(979):291-5. PubMed ID: 17488855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future treatment modalities for Clostridium difficile-associated disease.
    Halsey J
    Am J Health Syst Pharm; 2008 Apr; 65(8):705-15. PubMed ID: 18387898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
    Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
    CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan.
    Lee YC; Wang JT; Chen AC; Sheng WH; Chang SC; Chen YC
    J Microbiol Immunol Infect; 2012 Aug; 45(4):287-95. PubMed ID: 22209696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteremia due to a toxin A-negative, B-positive Clostridioides difficile ribotype 017 strain.
    Kachrimanidou M; Protonotariou E; Kaiafa G; Ζtrieva E; Skoura L; Savopoulos C; Kuijper E
    Anaerobe; 2020 Jun; 63():102195. PubMed ID: 32234350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile in long-term-care facilities for the elderly.
    Simor AE; Bradley SF; Strausbaugh LJ; Crossley K; Nicolle LE;
    Infect Control Hosp Epidemiol; 2002 Nov; 23(11):696-703. PubMed ID: 12452300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infections caused by Clostridium difficile].
    Rodríguez-Pardo D; Mirelis B; Navarro F
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):254-63. PubMed ID: 23411363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027.
    van der Kooi TII; Koningstein M; Lindemans A; Notermans DW; Kuijper E; van den Berg R; Boshuizen H; Filius PMG; van den Hof S
    J Med Microbiol; 2008 Jun; 57(Pt 6):709-716. PubMed ID: 18480327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.